| ▲ | yieldcrv 5 hours ago | |||||||
I’m annoyed by the bifurcated regulatory regime Substances approved by the FDA are done based on specific treatments, with multiple trials and approval per use case Substances declared scheduled are illegal by the substance itself, instead of per use case paradoxically because there is no FDA approved use case and almost no way to get one meaning that places in the US that diverge in legality and are ignored by the federal government have done so without any clinical trial, which would be some level of peer reviewed objective information by use case instead of the whole substance we can’t even get a simple list of side effects, or a disclaimer about what kind of users shouldn’t use it only anecdotes that annoys me and it’s not just about weed | ||||||||
| ▲ | dofm 5 hours ago | parent | next [-] | |||||||
The US government is now in thrall to the Kratom industry though isn't it? No reason to expect any logical consistency from them. (Literally the person currently responsible for the branch of government that keeps illegal drugs out of the country is an investor in a Kratom company) | ||||||||
| ||||||||
| ▲ | slipperybeluga 5 hours ago | parent | prev [-] | |||||||
The most ridiculous thing about cannabis remaining schedule 1 (high risk of abuse, no known medical use) so long is that there is both prescription THC and CBD. It should have been changed|to a higher (less strict) schedule decades ago with the release of marinol in 1985. Then we could have had a lot more studies being done. Needless to say, not easy to do studies on schedule 1 drugs. | ||||||||